Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqGS - Delayed Quote USD

Syndax Pharmaceuticals, Inc. (SNDX)

Compare
12.97
+0.96
+(7.99%)
At close: April 2 at 4:00:00 PM EDT
12.33
-0.64
(-4.93%)
Pre-Market: 4:05:50 AM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 7.68M
Earnings -94.17M

Q1'24

Q2'24

Q3'24

Q4'24

-80M
-60M
-40M
-20M
0
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

16.00
36.29 Average
12.97 Current
51.00 High

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 13121312
Avg. Estimate -1.24-0.99-3.79-2.75
Low Estimate -4.08-1.22-4.65-3.56
High Estimate -0.59-0.55-2.05-0.57
Year Ago EPS -0.85-0.8-3.72-3.79

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 12111312
Avg. Estimate 15.88M19.01M88.98M218.29M
Low Estimate 7.5M9.5M57.3M131.55M
High Estimate 36.6M39.3M175.24M381.45M
Year Ago Sales --3.5M23.68M88.98M
Sales Growth (year/est) 0.00%443.19%275.78%145.31%

Earnings History

Currency in USD 3/31/2024 6/30/2024 9/30/2024 12/31/2024
EPS Est. -0.99-0.91-1.06-0.23
EPS Actual -0.85-0.8-0.98-1.1
Difference 0.140.110.08-0.87
Surprise % 13.83%12.17%7.57%-380.58%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate -1.24-0.99-3.79-2.75
7 Days Ago -1.24-0.99-3.79-2.77
30 Days Ago -1.08-1.08-3.88-2.62
60 Days Ago -1.1-1.07-3.78-2.52
90 Days Ago -1.13-1.13-3.68-2.55

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days 1111
Up Last 30 Days 4464
Down Last 7 Days --------
Down Last 30 Days 3376

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
SNDX -46.10%-24.18%-1.89%27.56%
S&P 500 6.69%6.80%9.98%14.34%

Upgrades & Downgrades

Maintains JP Morgan: Overweight to Overweight 3/20/2025
Maintains JP Morgan: Overweight to Overweight 3/4/2025
Maintains Citigroup: Buy to Buy 3/4/2025
Reiterates HC Wainwright & Co.: Buy to Buy 3/4/2025
Maintains Scotiabank: Sector Perform to Sector Perform 1/8/2025
Reiterates HC Wainwright & Co.: Buy to Buy 12/10/2024

Related Tickers